0001724741-21-000001.txt : 20210222 0001724741-21-000001.hdr.sgml : 20210222 20210222115813 ACCESSION NUMBER: 0001724741-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210222 DATE AS OF CHANGE: 20210222 EFFECTIVENESS DATE: 20210222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EpiVax Therapeutics, Inc. CENTRAL INDEX KEY: 0001724741 IRS NUMBER: 815453645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390058 FILM NUMBER: 21658950 BUSINESS ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 BUSINESS PHONE: (401)272-2123 MAIL ADDRESS: STREET 1: 146 CLIFFORD STREET CITY: PROVIDENCE STATE: RI ZIP: 02903 FORMER COMPANY: FORMER CONFORMED NAME: EpiVax Oncology, Inc. DATE OF NAME CHANGE: 20171207 D 1 primary_doc.xml X0708 D LIVE 0001724741 EpiVax Therapeutics, Inc. 188 Valley Street Suite 424 PROVIDENCE RI RHODE ISLAND 02909 (401) 272-2123 DELAWARE EpiVax Oncology, Inc. Corporation true 2017 Anne De Groot 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Director William Martin 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Director Clifford Grimm 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Executive Officer Daniel Adams 188 Valley Street, Suite 424 Providence RI RHODE ISLAND 02909 Director Richard Lipkin 188 Valley Street Suite 424 Providence RI RHODE ISLAND 02909 Director Biotechnology Decline to Disclose 06b false 2020-08-07 false true true true true false 1 3000000 425000 2575000 false 6 0 true 0 true 0 true false EpiVax Therapeutics, Inc. /s/ Anne De Groot Anne De Groot President 2021-02-21